581 related articles for article (PubMed ID: 29482043)
1. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
Andreou D; Söderman E; Axelsson T; Sedvall GC; Terenius L; Agartz I; Jönsson EG
Psychiatry Res; 2015 Sep; 229(1-2):497-504. PubMed ID: 26142836
[TBL] [Abstract][Full Text] [Related]
3. Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers.
Nybäck H; Berggren BM; Hindmarsh T; Sedvall G; Wiesel FA
Psychiatry Res; 1983 Aug; 9(4):301-8. PubMed ID: 6196802
[TBL] [Abstract][Full Text] [Related]
4. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
6. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
De Bellis MD; Geracioti TD; Altemus M; Kling MA
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
Jönsson EG; Nöthen MM; Gustavsson JP; Neidt H; Bunzel R; Propping P; Sedvall GC
Psychiatry Res; 1998 Jun; 79(1):1-9. PubMed ID: 9676821
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
10. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-related genes and their relationships to monoamine metabolites in CSF.
Jönsson E; Sedvall G; Brené S; Gustavsson JP; Geijer T; Terenius L; Crocq MA; Lannfelt L; Tylec A; Sokoloff P; Schwartz JC; Wiesel FA
Biol Psychiatry; 1996 Nov; 40(10):1032-43. PubMed ID: 8915563
[TBL] [Abstract][Full Text] [Related]
12. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
13. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
Sedvall GC; Wode-Helgodt B
Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
[TBL] [Abstract][Full Text] [Related]
14. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
15. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.
Jibson M; Faull KF; Csernansky JG
Biol Psychiatry; 1990 Oct; 28(7):595-602. PubMed ID: 1699614
[TBL] [Abstract][Full Text] [Related]
16. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
[TBL] [Abstract][Full Text] [Related]
17. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
Jönsson EG; Goldman D; Spurlock G; Gustavsson JP; Nielsen DA; Linnoila M; Owen MJ; Sedvall GC
Eur Arch Psychiatry Clin Neurosci; 1997; 247(6):297-302. PubMed ID: 9477008
[TBL] [Abstract][Full Text] [Related]
20. Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment.
Härnryd C; Bjerkenstedt L; Grimm VE; Sedvall G
Psychopharmacology (Berl); 1979 Aug; 64(2):131-4. PubMed ID: 115032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
